Elsevier’s Oncology Journal Network Highlights | Elsevier
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Welcome to our Elsevier’s Oncology Journal Network Highlights page
Fred Hutch Obliteride is a bike ride and 5K that empowers people to help cure cancer faster by raising funds for Fred Hutchinson Cancer Center.
Prolonged administration of imatinib maintenance therapy for 6 years improved disease-free survival in patients with gastrointestinal stromal tumors.
Compared with ruxolitinib, momelotinib improved mild, moderate, and severe anemia in patients with myelofibrosis who were naive to JAK inhibitors, according to the phase 3…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Head and Neck Microvascular Reconstructive Workshop *BRAND NEW COURSE! Tuesday, May 14, 2024 at the Hyatt Regency Chicago Explore vital harvesting techniques for a…
Valerae Lewis, M.D., is a leader in the field of orthopedic oncology and chairs MD Anderson’s Orthopaedic Oncology department. Here, she shares what led her…
An abstract is unavailable.
Fuzuloparib with or without apatinib provided superior PFS benefit vs chemotherapy in HER2– metastatic breast cancer harboring germline BRCA1/2 mutations.
PHILADELPHIA (May 8, 2024) — On April 26, 2024, Fox Chase Cancer Center welcomed staff and faculty from Temple Health to the 10th Annual Cultural…
The American Cancer Society plans to follow 100,000 healthy black women for 30 years in the largest-of-its kind study into the demographic’s long- term health…